Ë¿¹ÏÊÓƵ

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.22.2.2
Stockholders' Equity (Tables)
6 Months Ended
Oct. 31, 2022
Stockholders' Equity Note [Abstract] Ìý
Schedule of Restricted Stock Unit Activity
A summary of the Company’s RSU activity, granted under the 2012 and 2018 Equity Incentive Plans, during the six months ended OctoberÌý31, 2022 is presented below:
Restricted Stock Units Number of Shares Weighted Average Grant Date Fair Value
Unvested balance outstanding, April 30, 2022 929,928Ìý $ 6.12Ìý
Granted —Ìý —Ìý
Forfeits (179,883) 7.69Ìý
Vested (189,693) 1 0.79Ìý
Expired —Ìý —Ìý
Unvested balance outstanding, October 31, 2022 560,352Ìý $ 7.42Ìý
___________________
1 Includes 123,448 RSUs that will be issued in the third quarter of fiscal year 2023.
Summary of Warrant Activity A summary of the Company’s warrant activity during the six months ended OctoberÌý31, 2022 is presented below:
Warrants Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Balance Outstanding, April 30, 2022 649,174Ìý $ 4.70Ìý 1.96 $ —Ìý
Granted —Ìý $ —Ìý —Ìý —Ìý
Exercised —Ìý $ —Ìý —Ìý —Ìý
Surrendered —Ìý $ —Ìý —Ìý —Ìý
Expired (224,174) $ 6.87Ìý —Ìý —Ìý
Balance Outstanding, October 31, 2022 425,000Ìý $ 3.56Ìý 3.27 $ —Ìý
Unvested (16,667)
Exercisable, October 31, 2022 408,333Ìý $ 3.42Ìý 3.17 $ —Ìý
Share-based Payment Arrangement, Option, Exercise Price Range
OUTSTANDING WARRANTS EXERCISABLE WARRANTS
Exercise
Price
Weighted
Average
Exercise
Price
Outstanding
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining Life
In Years
Exercisable
Number of
Warrants
$ 1.00Ìý 1.00Ìý 200,000Ìý $ 1.00Ìý 4.48 200,000Ìý
$ 4.89Ìý $ 4.89Ìý 50,000Ìý $ 4.89Ìý 1.44 50,000Ìý
$ 5.85Ìý $ 5.85Ìý 50,000Ìý $ 5.85Ìý 1.35 50,000Ìý
$ 6.00Ìý $ 6.00Ìý 100,000Ìý $ 6.00Ìý 3.84 100,000Ìý
$ 6.99Ìý $ 6.99Ìý 25,000Ìý $ 6.99Ìý 3.72 8,333Ìý
Ìý 425,000Ìý Ìý Ìý 408,333Ìý
OUTSTANDING OPTIONS EXERCISABLE OPTIONS
Exercise
Price
Weighted
Average
Exercise
Price
Outstanding
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining Life
In Years
Exercisable
Number of
Options
$3.24 to $4.38
$ 3.82Ìý 31,998Ìý $ 4.00Ìý 1.75 31,998Ìý
$4.50 to $5.20
$ 4.94Ìý 123,379Ìý $ 4.97Ìý 1.28 123,379Ìý
$7.17 to $7.55
$ 7.45Ìý 463,702Ìý $ 7.46Ìý 0.83 463,702Ìý
$8.57 to $9.07
$ 8.98Ìý 114,749Ìý $ 8.98Ìý 0.18 114,749Ìý
733,828Ìý 733,828Ìý
Summary of Stock Option Activity A summary of the Company’s stock option activity for employees and directors during the six months ended OctoberÌý31, 2022, is presented below:
Options Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Balance Outstanding, AprilÌý30, 2022
860,182Ìý $ 7.03Ìý 1.25 $ —Ìý
Granted —Ìý —Ìý —Ìý —Ìý
Exercised —Ìý —Ìý —Ìý —Ìý
Forfeited (36,634) 8.89Ìý —Ìý —Ìý
Expired (89,720) 5.53Ìý —Ìý —Ìý
Balance Outstanding, OctoberÌý31, 2022
733,828Ìý $ 7.12Ìý 0.86 $ —Ìý
Exercisable, OctoberÌý31, 2022
733,828Ìý $ 7.12Ìý 0.84 $ —Ìý
Schedule of Share-Based Compensation
A summary of the Company’s stock-based compensation expense, which is included in "general and administrative" expense in the consolidated statement of operations is presented below:


Three Months Ended October 31, Six Months Ended October 31,
2022 2021 2022 2021
RSUs $ 458,206Ìý $ 688,129Ìý $ 499,259Ìý $ 1,134,906Ìý
Restricted Stock —Ìý 10,525Ìý —Ìý 21,052Ìý
Stock options 130Ìý 23,504Ìý 5,407Ìý 108,912Ìý
Total stock-based compensation expense $ 458,336Ìý $ 722,158Ìý $ 504,666Ìý $ 1,264,870Ìý